PRRT2 and amyotrophic lateral sclerosis: Here, in ALS patient-specific iPSC-derived MNs, we observed a neuroprotective effect for PKC inhibition via Enzastaurin, that we speculate to be via activation of the AKT pro-survival pathway based on data from rat cerebellar granule cell neurons (Zhu et al., 2004).